Ergomed delivers agile, data-driven and fast study start-up.

A well-defined study start-up and activation strategy can significantly shorten your overall clinical trial, giving you a competitive advantage and improved chances of success.

At Ergomed, we begin study start-up and activation planning as early as the request for information (RFI) stage, developing a study start-up plan that will be enhanced throughout the bidding process so that it is ready when needed. Our global coverage and data-driven approach also ensure we can identify rapid start-up sites with the best patient population to deliver the ‘first patient in’ (FPI) milestone.

Led by a dedicated study start-up manager, we mobilize and synchronize our feasibility, site management and regulatory affairs resources to achieve even the most aggressive timelines.

As part of our innovative approach, our study start-up and activation teams:

  • Evaluate critical success factors and use our proprietary intelligence database to combine historical data, trends and the latest developments to tailor our study start-up plans.
  • Invest heavily in a robust, data-driven feasibility assessment at the outset to ensure we identify the right countries and sites.
  • Use our deep understanding of the many interrelated steps and dependencies that are critical to success.
  • Proactively mitigate risks and implement solutions to respond to the dynamic environment.
  • Take responsibility for expediting your study start-up and delivering reliable results, because predictability is the name of the game.

Want to know the possible timelines for your protocol? Use our startup timelines tool.


Startup timelines tool

These are estimated timelines based on a number of variable factors. Each project is unique and therefore timelines may be compressed or protracted. We would be happy to provide you with a tailored analysis based on your specific project and target milestones

Scroll and select
countries (max 10)

Select date of final protocol

These are estimated timelines. For tailored, granular assessment based on your project and target milestones, please contact us.